More about

Retinal Disease

News
March 31, 2021
1 min read
Save

Positive topline safety results reported for ONS-5010 in retinal disease treatment

Topline results from an open-label safety study investigating ONS-5010/Lytenava in the treatment of retinal diseases showed no unexpected safety results, according to a press release from Outlook Therapeutics.

News
March 18, 2021
3 min read
Save

What innovations will meet the challenges of undertreating retinal disease?

What innovations will meet the challenges of undertreating retinal disease?

Clinical trials have clearly laid out treatment protocols, usually with monthly treatment intervals, and the subjects tend to be compliant and motivated for the study visits. In the real world, life gets in the way.

News
March 18, 2021
2 min read
Save

Wealth of information benefits retina specialists worldwide

Wealth of information benefits retina specialists worldwide

The best source of evidence to base one’s clinical decisions on is a well-designed prospective randomized masked controlled clinical trial.

News
March 18, 2021
3 min read
Save

Practice strategies can help maintain high efficiency, quality care

Practice strategies can help maintain high efficiency, quality care

The COVID-19 pandemic has forced changes to practice routines that, in many cases, have come at the expense of efficiency.

News
March 18, 2021
11 min read
Save

Experts offer opinions on global trends in retina, part 2

Experts offer opinions on global trends in retina, part 2

In conjunction with the annual ASRS Preferences and Trends survey, retina specialists in Asia-Pacific, Africa and Middle East, Central-South America and Europe were invited to participate in the Global Trends in Retina Survey.

News
November 30, 2020
4 min watch
Save

VIDEO: Interaction between VEGF, Tie, integrin pathways plays a role in retinal disease

VIDEO: Interaction between VEGF, Tie, integrin pathways plays a role in retinal disease

Angiogenesis required the coordinated function of regulatory and effector proteins, including the VEGF, TIE, angiopoietin and integrin families, Peter K. Kaiser, MD, of the Cole Eye Institute at Cleveland Clinic, said in a video interview.

News
October 14, 2020
4 min watch
Save

VIDEO: Faricimab a step into new era of longer-lasting retinal disease therapies

VIDEO: Faricimab a step into new era of longer-lasting retinal disease therapies

At the virtual Euretina congress, Francesco Bandello, MD, speaks about faricimab, a drug that combines anti-VEGF and Ang-2-blocking properties.

News
September 22, 2020
3 min read
Save

Better delivery systems needed for retinal diseases

Better delivery systems needed for retinal diseases

The most common drugs injected into the vitreous to treat posterior segment disease are steroids and anti-VEGF medication. To keep it simple, I will use trade names when available.

News
August 11, 2020
1 min read
Save

OCU400 receives fourth orphan drug designation from FDA

The FDA has granted a fourth orphan drug designation for OCU400 to treat PDE6B gene mutation-associated retinal diseases, according to an Ocugen press release.

News
August 07, 2020
3 min watch
Save

VIDEO: Synthetic peptide may yield durable vision gains in retinal diseases

VIDEO: Synthetic peptide may yield durable vision gains in retinal diseases

In this video from the virtual American Society of Retina Specialists meeting, Peter K. Kaiser, MD, discusses AXT107, a synthetic peptide designed to treat wet age-related macular degeneration and macular edema.

View more